Pisarev VV et al. |
[Comparative study of azithromycin pharmacokinetics in healthy volunteers in open cross randomized procedure]. |
2003 |
Antibiot. Khimioter. |
pmid:15004973
|
DvoretskiÄ LI et al. |
[Levofloxacin and macrolides in chronic bronchitis exacerbation: comparative analysis of the treatment efficacy and nonrelapsing periods]. |
2007 |
Antibiot. Khimioter. |
pmid:18986021
|
Gomberg MA |
[Combined treatment of persisting urogenital chlamydia infection with sumamed and interferon alfa]. |
2002 |
Antibiot. Khimioter. |
pmid:12365322
|
Molchanova OV et al. |
[Antibiotic therapy of severe community-acquired pneumonia]. |
2009 |
Antibiot. Khimioter. |
pmid:19711847
|
Tets VV et al. |
[Characteristics of azithromycin action on bacterial biofilms of pneumonia pathogens]. |
2007 |
Antibiot. Khimioter. |
pmid:18476468
|
Saint-Criq V et al. |
Restoration of chloride efflux by azithromycin in airway epithelial cells of cystic fibrosis patients. |
2011 |
Antimicrob. Agents Chemother. |
pmid:21220528
|
Euba B et al. |
Relationship between azithromycin susceptibility and administration efficacy for nontypeable Haemophilus influenzae respiratory infection. |
2015 |
Antimicrob. Agents Chemother. |
pmid:25712355
|
Sato T et al. |
In vitro intracellular activity and in vivo efficacy of modithromycin, a novel bicyclolide, against Legionella pneumophila. |
2011 |
Antimicrob. Agents Chemother. |
pmid:21220530
|
Shigemura K et al. |
Azithromycin resistance and its mechanism in Neisseria gonorrhoeae strains in Hyogo, Japan. |
2015 |
Antimicrob. Agents Chemother. |
pmid:25712352
|
Waag DM |
Efficacy of postexposure therapy against glanders in mice. |
2015 |
Antimicrob. Agents Chemother. |
pmid:25645854
|
Peric M et al. |
Effects of an efflux mechanism and ribosomal mutations on macrolide susceptibility of Haemophilus influenzae clinical isolates. |
2003 |
Antimicrob. Agents Chemother. |
pmid:12604536
|
Seral C et al. |
Influence of P-glycoprotein inhibitors on accumulation of macrolides in J774 murine macrophages. |
2003 |
Antimicrob. Agents Chemother. |
pmid:12604540
|
Imamura Y et al. |
Azithromycin inhibits MUC5AC production induced by the Pseudomonas aeruginosa autoinducer N-(3-Oxododecanoyl) homoserine lactone in NCI-H292 Cells. |
2004 |
Antimicrob. Agents Chemother. |
pmid:15328111
|
Roblin PM et al. |
In vitro activities of rifamycin derivatives ABI-1648 (Rifalazil, KRM-1648), ABI-1657, and ABI-1131 against Chlamydia trachomatis and recent clinical isolates of Chlamydia pneumoniae. |
2003 |
Antimicrob. Agents Chemother. |
pmid:12604555
|
Liu P et al. |
Comparative pharmacokinetics of azithromycin in serum and white blood cells of healthy subjects receiving a single-dose extended-release regimen versus a 3-day immediate-release regimen. |
2007 |
Antimicrob. Agents Chemother. |
pmid:17060516
|
Rodvold KA et al. |
Intrapulmonary steady-state concentrations of clarithromycin and azithromycin in healthy adult volunteers. |
1997 |
Antimicrob. Agents Chemother. |
pmid:9174209
|
Soltow SM and Brenner GM |
Synergistic activities of azithromycin and amphotericin B against Naegleria fowleri in vitro and in a mouse model of primary amebic meningoencephalitis. |
2007 |
Antimicrob. Agents Chemother. |
pmid:17060522
|
Solomon AW et al. |
Impact of mass distribution of azithromycin on the antibiotic susceptibilities of ocular Chlamydia trachomatis. |
2005 |
Antimicrob. Agents Chemother. |
pmid:16251338
|
Kirkcaldy RD et al. |
Analysis of Neisseria gonorrhoeae azithromycin susceptibility in the United States by the Gonococcal Isolate Surveillance Project, 2005 to 2013. |
2015 |
Antimicrob. Agents Chemother. |
pmid:25451056
|
Nahata MC et al. |
Pharmacokinetics of azithromycin in pediatric patients after oral administration of multiple doses of suspension. |
1993 |
Antimicrob. Agents Chemother. |
pmid:8383944
|
Vaara M |
Outer membrane permeability barrier to azithromycin, clarithromycin, and roxithromycin in gram-negative enteric bacteria. |
1993 |
Antimicrob. Agents Chemother. |
pmid:8383945
|
Batt SL et al. |
Impact of azithromycin administration for trachoma control on the carriage of antibiotic-resistant Streptococcus pneumoniae. |
2003 |
Antimicrob. Agents Chemother. |
pmid:12936971
|
Brown ST et al. |
Azithromycin, rifabutin, and rifapentine for treatment and prophylaxis of Mycobacterium avium complex in rats treated with cyclosporine. |
1993 |
Antimicrob. Agents Chemother. |
pmid:8384809
|
Henry DC et al. |
Randomized double-blind study comparing 3- and 6-day regimens of azithromycin with a 10-day amoxicillin-clavulanate regimen for treatment of acute bacterial sinusitis. |
2003 |
Antimicrob. Agents Chemother. |
pmid:12936972
|
Goldman RC et al. |
Role of protonated and neutral forms of macrolides in binding to ribosomes from gram-positive and gram-negative bacteria. |
1990 |
Antimicrob. Agents Chemother. |
pmid:2159256
|
Ohrt C et al. |
Assessment of azithromycin in combination with other antimalarial drugs against Plasmodium falciparum in vitro. |
2002 |
Antimicrob. Agents Chemother. |
pmid:12121927
|
Gladue RP and Snider ME |
Intracellular accumulation of azithromycin by cultured human fibroblasts. |
1990 |
Antimicrob. Agents Chemother. |
pmid:2168141
|
Riska PF et al. |
Genetic and culture-based approaches for detecting macrolide resistance in Chlamydia pneumoniae. |
2004 |
Antimicrob. Agents Chemother. |
pmid:15328134
|
Goldstein EJ et al. |
Activities of telithromycin (HMR 3647, RU 66647) compared to those of erythromycin, azithromycin, clarithromycin, roxithromycin, and other antimicrobial agents against unusual anaerobes. |
1999 |
Antimicrob. Agents Chemother. |
pmid:10543769
|
Watt G et al. |
Azithromycin activities against Orientia tsutsugamushi strains isolated in cases of scrub typhus in Northern Thailand. |
1999 |
Antimicrob. Agents Chemother. |
pmid:10543774
|
Kutlin A et al. |
In vitro activities of azithromycin and ofloxacin against Chlamydia pneumoniae in a continuous-infection model. |
1999 |
Antimicrob. Agents Chemother. |
pmid:10471577
|
Bui KQ et al. |
Mononuclear and polymorphonuclear leukocyte dispositions of clarithromycin and azithromycin in AIDS patients requiring Mycobacterium avium complex prophylaxis. |
1999 |
Antimicrob. Agents Chemother. |
pmid:10471584
|
Grinwis ME et al. |
Macrolide and clindamycin resistance in Streptococcus milleri group isolates from the airways of cystic fibrosis patients. |
2010 |
Antimicrob. Agents Chemother. |
pmid:20404127
|
Sugie M et al. |
Possible involvement of the drug transporters P glycoprotein and multidrug resistance-associated protein Mrp2 in disposition of azithromycin. |
2004 |
Antimicrob. Agents Chemother. |
pmid:14982769
|
Loreto ES et al. |
New insights into the in vitro susceptibility of Pythium insidiosum. |
2014 |
Antimicrob. Agents Chemother. |
pmid:25223997
|
Schmalstieg AM et al. |
The antibiotic resistance arrow of time: efflux pump induction is a general first step in the evolution of mycobacterial drug resistance. |
2012 |
Antimicrob. Agents Chemother. |
pmid:22751536
|
Caceres SM et al. |
Enhanced in vitro formation and antibiotic resistance of nonattached Pseudomonas aeruginosa aggregates through incorporation of neutrophil products. |
2014 |
Antimicrob. Agents Chemother. |
pmid:25182651
|
den Hollander JG et al. |
Comparison of pharmacodynamics of azithromycin and erythromycin in vitro and in vivo. |
1998 |
Antimicrob. Agents Chemother. |
pmid:9527789
|
Bulman ZP et al. |
Influence of rhlR and lasR on Polymyxin Pharmacodynamics in Pseudomonas aeruginosa and Implications for Quorum Sensing Inhibition with Azithromycin. |
2017 |
Antimicrob. Agents Chemother. |
pmid:28096154
|
Pandori MW et al. |
Detection of azithromycin resistance in Treponema pallidum by real-time PCR. |
2007 |
Antimicrob. Agents Chemother. |
pmid:17620374
|
Hoffmann N et al. |
Azithromycin blocks quorum sensing and alginate polymer formation and increases the sensitivity to serum and stationary-growth-phase killing of Pseudomonas aeruginosa and attenuates chronic P. aeruginosa lung infection in Cftr(-/-) mice. |
2007 |
Antimicrob. Agents Chemother. |
pmid:17620382
|
Capobianco JO and Goldman RC |
Erythromycin and azithromycin transport into Haemophilus influenzae ATCC 19418 under conditions of depressed proton motive force (delta mu H). |
1990 |
Antimicrob. Agents Chemother. |
pmid:2178338
|
Gorby GL and McGee ZA |
Antimicrobial interference with bacterial mechanisms of pathogenicity: effect of sub-MIC azithromycin on gonococcal piliation and attachment to human epithelial cells. |
1990 |
Antimicrob. Agents Chemother. |
pmid:1982402
|
Bonnet M and Van der Auwera P |
Preincubation of Haemophilus influenzae with subinhibitory concentrations of macrolides: influence on human neutrophil chemiluminescence. |
1993 |
Antimicrob. Agents Chemother. |
pmid:8390808
|
Gordillo ME et al. |
In vitro activity of azithromycin against bacterial enteric pathogens. |
1993 |
Antimicrob. Agents Chemother. |
pmid:8390813
|
Kohlhoff SA et al. |
In vitro activity of a novel diaminopyrimidine compound, iclaprim, against Chlamydia trachomatis and C. pneumoniae. |
2004 |
Antimicrob. Agents Chemother. |
pmid:15105151
|
Singh S et al. |
Antimycobacterial drugs modulate immunopathogenic matrix metalloproteinases in a cellular model of pulmonary tuberculosis. |
2014 |
Antimicrob. Agents Chemother. |
pmid:24890593
|
Johnson MM et al. |
Effect of carbon dioxide on testing of susceptibilities of respiratory tract pathogens to macrolide and azalide antimicrobial agents. |
1999 |
Antimicrob. Agents Chemother. |
pmid:10428903
|
Geisler WM et al. |
Randomized, double-blind, multicenter safety and efficacy study of rifalazil compared with azithromycin for treatment of uncomplicated genital Chlamydia trachomatis infection in women. |
2014 |
Antimicrob. Agents Chemother. |
pmid:24798277
|
Kobuchi S et al. |
Transport of Azithromycin into Extravascular Space in Rats. |
2016 |
Antimicrob. Agents Chemother. |
pmid:27600045
|
Goldman RC and Capobianco JO |
Role of an energy-dependent efflux pump in plasmid pNE24-mediated resistance to 14- and 15-membered macrolides in Staphylococcus epidermidis. |
1990 |
Antimicrob. Agents Chemother. |
pmid:1963291
|
Hoppe JE and Bryskier A |
In vitro susceptibilities of Bordetella pertussis and Bordetella parapertussis to two ketolides (HMR 3004 and HMR 3647), four macrolides (azithromycin, clarithromycin, erythromycin A, and roxithromycin), and two ansamycins (rifampin and rifapentine). |
1998 |
Antimicrob. Agents Chemother. |
pmid:9559823
|
Navarro G et al. |
Image-based 384-well high-throughput screening method for the discovery of skyllamycins A to C as biofilm inhibitors and inducers of biofilm detachment in Pseudomonas aeruginosa. |
2014 |
Antimicrob. Agents Chemother. |
pmid:24295976
|
Binet R et al. |
Impact of azithromycin resistance mutations on the virulence and fitness of Chlamydia caviae in guinea pigs. |
2010 |
Antimicrob. Agents Chemother. |
pmid:20065052
|
Mallegol J et al. |
Antimicrobial activity of solithromycin against clinical isolates of Legionella pneumophila serogroup 1. |
2014 |
Antimicrob. Agents Chemother. |
pmid:24277019
|
Blais J et al. |
Inhibition of Toxoplasma gondii protein synthesis by azithromycin. |
1993 |
Antimicrob. Agents Chemother. |
pmid:8215287
|
Bermudez LE et al. |
Activity of moxifloxacin by itself and in combination with ethambutol, rifabutin, and azithromycin in vitro and in vivo against Mycobacterium avium. |
2001 |
Antimicrob. Agents Chemother. |
pmid:11120969
|
Dever LL et al. |
Comparative in vitro activities of clarithromycin, azithromycin, and erythromycin against Borrelia burgdorferi. |
1993 |
Antimicrob. Agents Chemother. |
pmid:8215288
|
Edelstein PH and Edelstein MA |
In vitro activity of azithromycin against clinical isolates of Legionella species. |
1991 |
Antimicrob. Agents Chemother. |
pmid:1849708
|
Ohara T et al. |
Effects of azithromycin on shiga toxin production by Escherichia coli and subsequent host inflammatory response. |
2002 |
Antimicrob. Agents Chemother. |
pmid:12384353
|
Fuentes F et al. |
Postanitbiotic and sub-MIC effects of azithromycin and isepamicin against Staphylococcus aureus and Escherichia coli. |
1998 |
Antimicrob. Agents Chemother. |
pmid:9527796
|
Kashuba AD and Amsden GW |
Bronchopulmonary pharmacokinetics of clarithromycin and azithromycin. |
1998 |
Antimicrob. Agents Chemother. |
pmid:9527816
|
Itaqui SR et al. |
In Vitro Synergism between Azithromycin or Terbinafine and Topical Antimicrobial Agents against Pythium insidiosum. |
2016 |
Antimicrob. Agents Chemother. |
pmid:27216049
|
Matic V et al. |
Antipneumococcal activities of two novel macrolides, GW 773546 and GW 708408, compared with those of erythromycin, azithromycin, clarithromycin, clindamycin, and telithromycin. |
2004 |
Antimicrob. Agents Chemother. |
pmid:15504828
|
Kosowska K et al. |
Activities of two novel macrolides, GW 773546 and GW 708408, compared with those of telithromycin, erythromycin, azithromycin, and clarithromycin against Haemophilus influenzae. |
2004 |
Antimicrob. Agents Chemother. |
pmid:15504829
|
Roblin PM et al. |
In vitro activity of trovafloxacin against Chlamydia pneumoniae. |
1997 |
Antimicrob. Agents Chemother. |
pmid:9303410
|
Berry V et al. |
Bacteriological efficacies of three macrolides compared with those of amoxicillin-clavulanate against Streptococcus pneumoniae and Haemophilus influenzae. |
1998 |
Antimicrob. Agents Chemother. |
pmid:9835514
|
Nahata MC et al. |
Pharmacokinetics of azithromycin in pediatric patients with acute otitis media. |
1995 |
Antimicrob. Agents Chemother. |
pmid:7486938
|
Chisholm SA et al. |
High-level azithromycin resistance occurs in Neisseria gonorrhoeae as a result of a single point mutation in the 23S rRNA genes. |
2010 |
Antimicrob. Agents Chemother. |
pmid:20585125
|
Tomazic J et al. |
Ex vivo effect of azithromycin in human leukocyte bactericidal functions. |
1995 |
Antimicrob. Agents Chemother. |
pmid:7486947
|
Ouyang-Latimer J et al. |
In vitro antimicrobial susceptibility of bacterial enteropathogens isolated from international travelers to Mexico, Guatemala, and India from 2006 to 2008. |
2011 |
Antimicrob. Agents Chemother. |
pmid:21115800
|
O'Reilly T et al. |
Relationship between antibiotic concentration in bone and efficacy of treatment of staphylococcal osteomyelitis in rats: azithromycin compared with clindamycin and rifampin. |
1992 |
Antimicrob. Agents Chemother. |
pmid:1336342
|
Deshpande D et al. |
Azithromycin Dose To Maximize Efficacy and Suppress Acquired Drug Resistance in Pulmonary Mycobacterium avium Disease. |
2016 |
Antimicrob. Agents Chemother. |
pmid:26810646
|
Heifets L et al. |
Mycobacterium avium strains resistant to clarithromycin and azithromycin. |
1993 |
Antimicrob. Agents Chemother. |
pmid:8031351
|
Vazifeh D et al. |
Cellular accumulation of the new ketolide RU 64004 by human neutrophils: comparison with that of azithromycin and roxithromycin. |
1997 |
Antimicrob. Agents Chemother. |
pmid:9333032
|
Wolinsky E |
Mycobacterium avium strains resistant to clarithromycin and azithromycin. |
1994 |
Antimicrob. Agents Chemother. |
pmid:8031406
|
Taylor WR et al. |
Tolerability of azithromycin as malaria prophylaxis in adults in northeast papua, indonesia. |
2003 |
Antimicrob. Agents Chemother. |
pmid:12821468
|
Nakajima T et al. |
Microbiological and Clinical Effects of Sitafloxacin and Azithromycin in Periodontitis Patients Receiving Supportive Periodontal Therapy. |
2016 |
Antimicrob. Agents Chemother. |
pmid:26729495
|
Seral C et al. |
Quantitative analysis of gentamicin, azithromycin, telithromycin, ciprofloxacin, moxifloxacin, and oritavancin (LY333328) activities against intracellular Staphylococcus aureus in mouse J774 macrophages. |
2003 |
Antimicrob. Agents Chemother. |
pmid:12821480
|
Ravdin JI and Skilogiannis J |
In vitro susceptibilities of Entamoeba histolytica to azithromycin, CP-63,956, erythromycin, and metronidazole. |
1989 |
Antimicrob. Agents Chemother. |
pmid:2548442
|
Kawai Y et al. |
Therapeutic efficacy of macrolides, minocycline, and tosufloxacin against macrolide-resistant Mycoplasma pneumoniae pneumonia in pediatric patients. |
2013 |
Antimicrob. Agents Chemother. |
pmid:23459497
|
Viscardi RM et al. |
Azithromycin to prevent bronchopulmonary dysplasia in ureaplasma-infected preterm infants: pharmacokinetics, safety, microbial response, and clinical outcomes with a 20-milligram-per-kilogram single intravenous dose. |
2013 |
Antimicrob. Agents Chemother. |
pmid:23439637
|
Ressner RA et al. |
Antimicrobial susceptibilities of geographically diverse clinical human isolates of Leptospira. |
2008 |
Antimicrob. Agents Chemother. |
pmid:18411316
|
Gunell M et al. |
In vitro activity of azithromycin against nontyphoidal Salmonella enterica. |
2010 |
Antimicrob. Agents Chemother. |
pmid:20498312
|
Carvalho-Assef AP et al. |
Detection of NDM-1-, CTX-M-15-, and qnrB4-producing Enterobacter hormaechei isolates in Brazil. |
2014 |
Antimicrob. Agents Chemother. |
pmid:24449772
|
Roblin PM and Hammerschlag MR |
Microbiologic efficacy of azithromycin and susceptibilities to azithromycin of isolates of Chlamydia pneumoniae from adults and children with community-acquired pneumonia. |
1998 |
Antimicrob. Agents Chemother. |
pmid:9449287
|
Goldstein EJ et al. |
Activities of HMR 3004 (RU 64004) and HMR 3647 (RU 66647) compared to those of erythromycin, azithromycin, clarithromycin, roxithromycin, and eight other antimicrobial agents against unusual aerobic and anaerobic human and animal bite pathogens isolated from skin and soft tissue infections in humans. |
1998 |
Antimicrob. Agents Chemother. |
pmid:9593139
|
Spangler SK et al. |
Postantibiotic effect and postantibiotic sub-MIC effect of levofloxacin compared to those of ofloxacin, ciprofloxacin, erythromycin, azithromycin, and clarithromycin against 20 pneumococci. |
1998 |
Antimicrob. Agents Chemother. |
pmid:9593160
|
Pankuch GA et al. |
In vitro selection of resistance to four beta-lactams and azithromycin in Streptococcus pneumoniae. |
1998 |
Antimicrob. Agents Chemother. |
pmid:9797225
|
Roblin PM and Hammerschlag MR |
In vitro activity of a new ketolide antibiotic, HMR 3647, against Chlamydia pneumoniae. |
1998 |
Antimicrob. Agents Chemother. |
pmid:9624507
|
Amsden GW et al. |
Pharmacokinetics in serum and leukocyte exposures of oral azithromycin, 1,500 milligrams, given over a 3- or 5-day period in healthy subjects. |
1999 |
Antimicrob. Agents Chemother. |
pmid:9869584
|
Gelber RH et al. |
Activities of various macrolide antibiotics against Mycobacterium leprae infection in mice. |
1991 |
Antimicrob. Agents Chemother. |
pmid:1648889
|
Gladue RP et al. |
In vitro and in vivo uptake of azithromycin (CP-62,993) by phagocytic cells: possible mechanism of delivery and release at sites of infection. |
1989 |
Antimicrob. Agents Chemother. |
pmid:2543276
|
Woosley LN et al. |
CEM-101 activity against Gram-positive organisms. |
2010 |
Antimicrob. Agents Chemother. |
pmid:20176910
|
Pérez-MartÃnez I and Haas D |
Azithromycin inhibits expression of the GacA-dependent small RNAs RsmY and RsmZ in Pseudomonas aeruginosa. |
2011 |
Antimicrob. Agents Chemother. |
pmid:21537014
|
Hoffman HL et al. |
Influence of macrolide susceptibility on efficacies of clarithromycin and azithromycin against Streptococcus pneumoniae in a murine lung infection model. |
2003 |
Antimicrob. Agents Chemother. |
pmid:12543686
|
Odenholt I et al. |
Studies of the killing kinetics of benzylpenicillin, cefuroxime, azithromycin, and sparfloxacin on bacteria in the postantibiotic phase. |
1997 |
Antimicrob. Agents Chemother. |
pmid:9371360
|
Kosowska-Shick K et al. |
Activity of DX-619 compared to other agents against viridans group streptococci, Streptococcus bovis, and Cardiobacterium hominis. |
2006 |
Antimicrob. Agents Chemother. |
pmid:17043120
|
Phillips-Campbell R et al. |
Induction of the Chlamydia muridarum stress/persistence response increases azithromycin treatment failure in a murine model of infection. |
2014 |
Antimicrob. Agents Chemother. |
pmid:24342653
|
Jang MO et al. |
Outcome of intravenous azithromycin therapy in patients with complicated scrub typhus compared with that of doxycycline therapy using propensity-matched analysis. |
2014 |
Antimicrob. Agents Chemother. |
pmid:24366734
|